Competition & Innovation Lab

  • Home
  • Who We Are
    • Mission
    • Get Involved
    • Our Research Themes
    • Donate
  • News
  • Events
  • Publications
  • Academies
    • Antitrust Academy
    • AI Academy
  • Regional Initiatives
  • Contact
Give to the Lab
The EU’s Investigation Into Microsoft Teams: A Preliminary Assessment

The EU’s Investigation Into Microsoft Teams: A Preliminary Assessment

by bacenter | Jul 8, 2024 | Data, Trade & National Security, Intellectual Property Rights, Working Papers

EU has opened an antitrust investigation into Microsoft’s policy of including the communication software Teams in its Office 365 packages. Very little is known about the case and the alleged grievances, as only a short press statement is available. This...
Rethinking the Legal Test for Excessive Pricing

Rethinking the Legal Test for Excessive Pricing

by bacenter | Jun 27, 2024 | Intellectual Property Rights, Working Papers

Insights from the landmark UK CMA v Pfizer/Flynn Case and its legal implications The legal treatment of excessive pricing in the pharmaceutical sector has been a topic of intense debate. This article examines the UK Competition and Market Authority (CMA) approach in...
Antitrust and Intellectual Property Rights: Toward a New Schumpeterian Approach

Antitrust and Intellectual Property Rights: Toward a New Schumpeterian Approach

by bacenter | Jan 6, 2024 | Intellectual Property Rights, Working Papers

The protection of intellectual property rights is worsening, but populist antitrust enforcement is expanding. Both tendencies inhibit the process of innovation. An alternative approach to antitrust and intellectual property is both conceivable and essential. Rising...
Next Entries »

Recent Posts

  • Foundation Models and Generative AI Applications: What Competitive Concerns?
  • Platform Power and Digital Regulation: Global Lessons, Local Realities – Esin Aygun
  • The Future of Competition Law in a Rapidly Changing Global Order – Antonio Capobianco
  • Draft Technology Transfer Guidelines Further Show that the Future Markets Model is the Administrable Framework for Protecting Innovation
  • No Doctor, No Problem: The Benefits of Innovation Expanding OTC Drug Access

Recent Comments

No comments to show.

The Competition & Innovation Lab

Washington DC, 20052
Email:contact@thegwcg.com

  • Follow
  • Follow
  • Follow